Merck Serono, Roche, GSK and Baxalta feature in line up at Smithers Rapra Extractables and Leachables European Conference 2015

9th European Extractables and Leachables conference to be held in London, UK on 10-12 November 2015

Extractables and Leachables (E&L Europe) conference full agenda for 2015 has been revealed. The 3 day event will feature two pre-conference workshops led by Smithers Rapra and GlaxoSmithKline, a two day speaker programme covering analytical advances in E&Ls and best practises from working groups, toxicologists and expert pharmaceutical representatives, plus poster sessions and extended networking opportunities.

Smithers Rapra’s last E&L conference, in the US, saw a record attendance of delegates, with over 130 pharmaceutical manufacturers, medical device manufacturers, packaging and materials suppliers, CROs, government representatives and academics in attendance. Additionally, in coming back to London, a popular location for this event in recent years, Smithers Rapra are looking forward to another stellar event, to ensure safe deliverance of pharmaceuticals.

The conference programme will feature unique supply chain perspectives, considering the identification and management of risk along the supply chain, case studies of biotech manufacturing at Merck Serono and E&Ls from filter materials, plus the analysis of special surfaces at Roche production sites. E&L expert Dennis Jenke of Baxter Healthcare will also join us to share new research on moving towards standardised analytical methods, which in addition to presentation of a complete analytical workflow for extractable and leachable impurities from Thermo Fisher Scientific, E&L Europe will bring you the freshest content throughout the two day agenda. 

This year’s panel discussion will take a comprehensive look at best practise for single-use systems, providing all attendees with the chance to get up to speed with current approved best practises for product testing. Perspectives from BPOG and BPSA will be shared in this session and will cover proposed risk assessment, leachable study design and leachable test methods.

Further highlights of the conference include related toxicological evaluations and risk assessments of E&Ls from both medical devices and specifically process aids from Paolo Pescio of Eurofins Biopharma Product Testing and Carsten Senholt at Novo Nordisk, respectively.  Plus we welcome a presentation of the USP's approach to extractables and leachables for drug product containers and elastomeric closures from a new face to E&L Europe; Dr Michael N. Eakins.

For 2015, Smithers Rapra are also offering a full day of pre-conference workshops and are pleased to announce that for the first time, GlaxoSmithKline will be collaborating with Smithers Rapra to lead an intermediate level workshop showing how a risk-based approach can successfully be applied to E&L. Places for this workshop are limited and if you require an introduction to extractables and leachables, material selection, risk based analysis and extractable and leachable testing, it is recommended to also register for our introductory workshop, led by Dr. Andrew Feilden, Chemistry Operations Director at Smithers Rapra.

For more information on E&L Europe 2015 visit www.eandl-conference.com 

View more information on Smithers Rapra www.smithersrapra.com

Contact
Adriana Lobo
+44 (0)1372 802000
alobo@smithers.com